Terry Levy
Overview
Explore the profile of Terry Levy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
593
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hinton J, Tuffs C, Varma R, Hurwitz-Bremner R, Hein A, Kwok C, et al.
Catheter Cardiovasc Interv
. 2024 May;
104(1):27-33.
PMID: 38769732
Background: Excimer laser atherectomy (ELCA) is an established adjunctive technique to facilitate acute success in percutaneous coronary intervention (PCI). Despite this there are a lack of contemporary outcome data, particulary...
2.
Hinton J, Ashinne B, Levy T, Wiles B
Heart
. 2023 Jan;
109(5):411-412.
PMID: 36627182
No abstract available.
3.
Hinton J, Mariathas M, Chan E, Patel A, Singh S, Konstantinou K, et al.
Catheter Cardiovasc Interv
. 2022 Dec;
101(2):243-249.
PMID: 36490226
Introduction: Stent under-expansion due to calcification is associated with a less durable result. The development of intravascular lithotripsy (IVL) has provided clinicians with a readily available, simple-to-use treatment option for...
4.
Azizi M, Mahfoud F, Weber M, Sharp A, Schmieder R, Lurz P, et al.
JAMA Cardiol
. 2022 Nov;
7(12):1244-1252.
PMID: 36350593
Importance: Although early trials of endovascular renal denervation (RDN) for patients with resistant hypertension (RHTN) reported inconsistent results, ultrasound RDN (uRDN) was found to decrease blood pressure (BP) vs sham...
5.
Rader F, Kirtane A, Wang Y, Daemen J, Lurz P, Sayer J, et al.
EuroIntervention
. 2022 Aug;
18(8):e677-e685.
PMID: 35913759
Background: While the blood pressure (BP)-lowering effect of renal denervation (RDN) has been established, long-term durability is a key prerequisite for a broader clinical implementation. Aims: Our aims were to...
6.
Sanghvi K, Wang Y, Daemen J, Mathur A, Jain A, Dohad S, et al.
Cardiovasc Revasc Med
. 2021 Oct;
39:58-65.
PMID: 34620570
Purpose: To assess the variability of renal artery (RA) anatomy and presence of RA-pathology in patients with mild-to-moderate hypertension enrolled in the RADIANCE-HTN SOLO trial. Background: RADIANCE-HTN SOLO was a...
7.
Azizi M, Sanghvi K, Saxena M, Gosse P, Reilly J, Levy T, et al.
Lancet
. 2021 May;
397(10293):2476-2486.
PMID: 34010611
Background: Endovascular renal denervation reduces blood pressure in patients with mild-to-moderate hypertension, but its efficacy in patients with true resistant hypertension has not been shown. We aimed to assess the...
8.
Tomlinson J, Patel A, Levy T
Eur Heart J Case Rep
. 2021 Mar;
5(2):ytab015.
PMID: 33738416
Background: Coronary vasospasm can present like an acute coronary syndrome (ACS) with an intense vasoconstriction resulting in total or near-total occlusion of one or more of the coronary vessels. Definitive...
9.
Azizi M, Daemen J, Lobo M, Mahfoud F, Sharp A, Schmieder R, et al.
JACC Cardiovasc Interv
. 2020 Dec;
13(24):2922-2933.
PMID: 33357531
Objectives: This study reports the 12-month results of the RADIANCE-HTN (A Study of the ReCor Medical Paradise System in Clinical Hypertension) SOLO trial following unblinding of patients at 6 months....
10.
Lobo M, Sharp A, Kapil V, Davies J, de Belder M, Cleveland T, et al.
Heart
. 2019 Jul;
105(19):1456-1463.
PMID: 31292190
Improved and durable control of hypertension is a global priority for healthcare providers and policymakers. There are several lifestyle measures that are proven to result in improved blood pressure (BP)...